SUMMARY Regional cerebral blood flow was investigated using single photon emission computed tomography and xenon-133 intravenous injection in six patients with dementia of the Alzheimer type (DAT) with atypical focal clinical presentation, and in 20 age-matched healthy volunteers. The patients had a progressive and preponderant cognitive deficit and a focal hypoperfusion that correlated with the neuropsychological findings, whereas the average flow did not significantly differ from that of controls. The assessment of concordant haemodynamic and neuropsychological focal abnormalities could be useful in the diagnosis of atypical cases of DAT.
Alzheimer's disease (AD) and dementia of the Alzheimer type (DAT) have long been considered as characterised by a progressive, diffuse and rather homogeneous impairment of cognitive functions. However, isolated or prominent cognitive dysfunction, especially language alterations, have been described in the disease' 3 or related to a selective cerebral degeneration. 4 Histopathological changes especially in the temporoparietal regions have been reported too.5 Measurements of local cerebral glucose metabolism by positron emission tomography (PET) or isopropylamphetamine distribution by single photon emission computed tomography (SPECT) have pointed to a bilateral temporoparietal metabolic decrease in Alzheimer's disease.6-9 Recently, Friedland et al'0 and Haxby et al" emphasised hemispheric asymmetries in demented patients. We studied six patients with DAT and focal oligaemia. In this paper, we compare their haemodynamic status with that obtained from a control group and report the relationships between the regional cerebral blood flow (rCBF) of the patients and their performances on specific cognitive tests.
Patients
Out of a series of 36 patients with DAT who underwent a rCBF evaluation by SPECT, we studied six right-handed subjects aged 57 to 75 years (mean age 66 + 81). When referred for the first time to the Department of Neurology, three of them exhibited an elective cognitive deficit, the other three a more diffuse alteration with, however, a disproportionate impairment of one of the cortical functions. Along with the duration of symptoms, that ranged from 1 to 7 years, successive medical evaluations included physical and neurological examinations, neuropsychological testing, laboratory tests, EEGs and CT scans. None of the patients had a family history of DAT. Subjects were free from any motor or sensory deficit. None had a history of cerebrovascular disease (Hachinski ischaemic score"2 of three or less) and in the two cases where it was performed, the digital angiography was normal. The cerebrospinal fluid (CSF) was studied in three patients and the results were within normal limits. In all cases, folic acid deficiency, hypothyroidism, tertiary neurosyphilis and pernicious anaemia were excluded. EEGs were normal or without obvious focal abnormality. CT scans were normal or showed mild, diffuse cerebral atrophy, sometimes predominating in one of the hemispheres. In each case, neuropsychological evaluation demonstrated a progressive deterioration of intellectual and mnesic abilities in addition to the selective or prominent cognitive deficit. At an early stage of the disease, the symptoms met the criteria for the clinical diagnosis of possible Alzheimer's disease, as given in the report of the NINCDS-ADRDA Work Group on the diagnosis of Alzheimer's disease. 3 At the time of the flow study, the patients met the criteria of the Work Group for the diagnosis of probable Alzheimer's disease and all six Focal hypoperfusion in dementia of Alzheimer type patients exhibited symptoms that met the diagnostic criteria for Primary Degenerative Dementia given in the Diagnostic and Statistical Manual of Mental Disorders.14 Before the CBF study, informed consent was obtained from the patients or their relatives. Three of them (cases 1, 2 and 6) were retested 8 to 12 months later.
Controls
We measured cerebral blood flow at rest in 20 age-matched controls (mean age 65 + 5 2 years). They underwent clinical and neuropsychological evaluations in order to exclude cerebrovascular disease and cognitive impairment. Ten controls were retested 1 year later. Written informed consent was obtained from the normal volunteers.
CBF measurement
Regional cerebral blood flow was assessed using a single photon emission tomograph (Tomomatic 64, Medimatic, Copenhagen) and intravenous injection of xenon 133 (2220 MBeq, 60 mCi). Data were collected from three transverse slices simultaneously, each of 2cm thickness, parallel and centred at 1, 5 and 9cm above the canthomeatal plane respectively. The in-plane resolution was 1-7 cm. During the 4 minute data collection, patients were kept at rest, eyes closed, and pCO2 was continuously recorded using a cutaneous electrode and a Kontron 634 pCO2 monitor. fig 1, namely the right and left frontal (F), Sylvian (S) and parietotemporal (PT) cortical regions, the middle frontal (MF) and middle occipital (MO) cortical regions, and the right and left anterior and posterior subcortical regions (ASC and PSC respectively). The ROIs were determined using a semiautomatic method, which first consisted in delimiting the outer contour of the brain by thresholding. Then, the length of the saggital axis (that is, the distance between the frontal and occipital poles), expressed in pixels, was automatically calculated. Two horizontal lines were drawn on the screen: the first at a distance from the most anterior point of the frontal pole equal to 25% of the saggital length; the second at a distance equal to 60% of the saggital length. The first line corresponded to the limit between the frontal (F) and Sylvian (S) regions and gave the anterior limit of the ASC region. The second line corresponded to the limit between the Sylvian (S) and parietotemporal (PT) regions and gave the posterior limit of the PSC region. Then, according to this scheme, the ROIs were drawn using predefined templates. 
Results
The main results of the neuropsychological testing and SPECT study of cerebral perfusion are summarised in table 1. Global CBFfindings Controls Mean flow in the control group was equal to 50 6 + 9-8 ml/lOOg/min. Hemispheric flow was 50 + 9 5 and 51-1 + 10-5 in the left and right hemisphere respectively. The average percent difference between homologous ROIs never exceeded 6-5 (table  2) . The average percent difference between hemispheres was equal to 3-1 + 2-4, the individual difference never exceeding 7%. In the group of 10 retested controls, mean flow was equal to 52 3 + 9-2 ml/100g/min at the first measurement and to 54-6 + 8&3 at the second assessment, the difference being not significant. Furthermore, there was no correlation between the hemispheric asymmetries, expressed in percent difference, that were observed at the first and second CBF evaluation, neither for the hemispheres nor for any of the ROIs.
Patients All patients exhibited a focal hypoperfusion in one of the hemispheres. Global mean flow was equal to 47 7 + 8-5 ml/1OOg/min and did not significantly differ from the average flow observed in controls. In the hemispheres with focal hypoperfusion, flow was equal to 46-3 + 8 2 and, in the hemispheres without focal hypoperfusion, to 50-2 + 8-9 ml/100g/min, a value very close to the mean value observed in the control group. The average percent difference between hemispheres equalled 8 + 4a2 and significantly differed from the value obtained in controls (p < 0.01). All three patients who were retested 1 year later still exhibited focal hypoperfusion, the localisation and extent of which were quite similar to those observed at the first examination. 28 ). Calculation and memory were impaired, as shown by MMS evaluation (see above) and Benton VRT (3/10). However, the outstanding neuropsychological deficits called attention to a focal left dysfunction, and more especially to the anterior region since the patient presented with non-fluent aphasia. Yet, the neurological examination, EEG and CSF were strictly normal and a CT scan showed a mild cortical atrophy, more pronounced in the left hemisphere (fig 2c) . The flow study supported the neuropsychological examination. On the CBF map corresponding to slice 2 (fig 2d) , a cortical hypoperfusion was clearly seen in the left frontal region. The local percent difference reached 33%, compared with the opposite ROI (table  1) . Low flow was also found in the left anterior subcortical area (52 vs 59 ml/lOOg/min). In the other ROIs, flow was slightly depressed by about 6% on the left side but the mean left and right hemispheric values, 58 and 64 ml/lOOg/min respectively, showed that the brain, as a whole, was correctly perfused. and basal ganglia. In slices 1 and 3, the flow was also diminished in the left hemisphere (about 10%) but the overall perfusion level was good since mean flow in the three slices averaged 50 ml/lOOg/min.
Celsis, Agniel, Puel, Rascol, Marc-Vergnes Case 5 A 72 year old woman was hospitalised in 1985 for word-finding difficulties, poor memory and mild temporospatial disorientation of approximately 3 month duration. She was aware of her troubles and anxious. Neuropsychological testing evidenced a deficit in a number of cognitive abilities. MMS score was equal to 23: orientation 6/10, registration 3/3, attention and calculation 5/5, recall 0/3, and language 9/9. However, an ideomotor apraxia predominating at the left superior limb, a constructional apraxia due to an important deficit in visuospatial perception as well as signs of left visual hemineglect (score on ROCF copying test equal to 28 with most of the errors in the left side), a left-ear relative extinction on dichotic test and a spatiotemporal disorientation that the patient tried to correct by logical and deductive reasoning, suggested that cortical dysfunction was more severe on the right side. Normal language capacities supported this hypothesis. The patient had also some difficulty in recognising ward personnel and exhibited euphoric behaviour. Neurological examination and cerebrospinal fluid were normal. An EEG showed right temporal and parietal slowing. CT scan was unremarkable. The 3-D flow study demonstrated an elective, moderate hypoperfusion of the right Sylvian region (table 1) . In contrast, compared with the left side, flow was about 5% higher in the other right ROIs. On the average, perfusion was identical for both hemispheres and equalled 51 ml/100g/min in slice 2, a value that could be considered normal in a 72 year old patient.
Case 6
In 1982, three years before admission, this 75 year old woman started to complain of memory troubles. At the time she was hospitalised, neuropsychological testing showed deterioration. Memory was strongly impaired: a verbal learning test of 10 words was impossible. Temporospatial disorientation was complete. The patient achieved 16 on MMS score (orientation 1/10, registration 3/3, attention and calculation 5/5, recall 0/3, language 7/9). But, surprisingly, among signs of diffuse deterioration, left hemivisual and hemimotor neglects were noted.
Moreover, examination demonstrated an important constructional apraxia (O on WAIS block design subtest) and an upper-limb bilateral ideomotor apraxia, more pronounced on the left side. Compared with other functions, language was preserved, fluent, and difficulty only appeared in elaborating a complex, abstract sentence. The patient was partially aware of her difficulties. The EEG showed theta waves in the right hemisphere and the CT scan was remarkable only for mild, diffuse atrophy (fig 2g) . 3-D CBF measurement exhibited a global hypoperfusion (39 and 36 Focal hypoperfusion in dementia of Alzheimer type ml/1OOg/min in left and right hemisphere respectively), with a reduction in right relative to left parietotemporal region of about 15% (fig 2h) .
Discussion
Obviously, for lack of histopathological evidence, the diagnosis of Alzheimer's disease can be founded only on the medical history, clinical examination, neuropsychological tests and laboratory studies. From the information thus recorded from our patients, the diagnosis of primary degenerative dementia could be established according to the criteria given in the DSM III,14 whereas the diagnosis of probable Alzheimer's disease would apply, according to the criteria of McKhann et al. 13 Therefore, taking into account both the two possible terms, the age of the patients and also to comply with current use in recent literature, we chose the term "dementia of the Alzheimer type" (DAT) to describe our patients.
In our patients, the average flow was not significantly lower than in controls. Besides, flow calculated from the hemispheres with focal hypoperfusion did not differ significantly from the mean value obtained in controls. In the hemispheres without hypoperfusion, the values were within the range of the mean flows observed in controls. Differences between patients and controls only appeared when looking for regional asymmetries. Compared with age-matched controls, bilateral symmetrical reduction of flow has been described in Alzheimer's disease, using the xenon-133 inhalation technique and stationary detectors. 26 27 Tomographic data on CBF in DAT, far from being numerous, essentially consist of those produced by Frackowiak et al,28 using ol5, who also found bilateral hypoperfusions. Measurement of cerebral glucose rate with PET has also demonstrated bilateral significant diminution in patients with DAT.6 29 30 The differences between our results and those reported in the works mentioned above are not due to the technique, as we also, using SPECT, have observed global bilateral decrease in other demented patients, but depend on patient selection. This selection also resulted in the fact that only two cases (Nos I and 6) showed a global hypoperfusion, thus achieving a very atypical grouping of demented patients.
All six patients manifested a progressive mental impairment that gradually involved several cognitive functions, so that they could be termed demented. Indeed, for three of them (cases 3, 5 and 6), the diagnosis of dementia had been put forward from the beginning. But they exhibited a disproportionate failure of a specific cognitive capacity: patients I to 4 initially showed preponderant language deficits while 1609 patients 5 and 6 evidenced a prominent contructional apraxia and left visual and motor hemineglects. Some authors have recently insisted on progressive language alteration in DAT.1 Kirshner et al2 have suggested a continuous spectrum from isolated aphasia to generalised dementia. Mesulam4 suggested that this clinical syndrome could result from a preferential involvement of the left perisylvian region, a special type of progressive degenerative disorder. Recently, Chawluk et al31 reported two cases of slowly progressive aphasia with striking abnormalities of glucose utilisation in the left hemisphere, without any contralateral impairment, as demonstrated by PET. They stressed that their patients did not present with generalised dementia. Our cases have prompted us to a view close of that of Kirshner et al because our patients with prominent language alteration showed a frontal or parietotemporal hypoperfusion and because mild signs of memory failure and reasoning impairment appeared relatively soon in progression of the disease. Since the first CBF examination, in 1985, one of these patients (case 1), whose language alteration remained by far the most striking-if not the only appreciable-disorder for the 3 or 4 years after onset, has become incontinent.
Concerning the right hemisphere, Crystal et a132 reported a patient with biopsy-proved Alzheimer's disease who presented with a right parietal syndrome, 2 years before intellectual impairment appeared. They suggested that the parietal lobes could be initially more affected than other regions. Indeed, two of our patients (cases 5 and 6) evidenced a preponderant dysfunction of the right hemisphere involving the parietal region, but including signs of temporal impairment in case 5. Also considering all six patients, the frontal and perisylvian regions appeared to be initially affected as well. So, our findings might suggest that DAT could begin with different kinds of selective cognitive impairment, related to a left as well as a right hemispheric flow disturbance likely to be shown by haemodynamic studies.
The most striking fact was that all six patients showed a focal cerebral hypoperfusion which was consistent with the neuropsychological findings. This focal hypoperfusion was not a simple hemispheric asymmetry, a finding emphasised by Friedland et al,10 and which we observed frequently in the remaining patients of our complete series studied by SPECT who presented as mild to moderate Alzheimer's disease. The decrease in flow was indeed wellcircumscribed, sometimes accompanied by a slight global reduction in the ipsilateral hemisphere. Such a haemodynamic pattern resembled those observed in stroke patients. But our patients were not stroke patients. First, they experienced a very slowly progressive deterioration in cognitive ability. Evi- 29 35 Using MRI, Besson et at36 found a negative correlation between the constructional subscores and the changes in spin-lattice relaxation time in the parietal regions. The limited number of cases did not allow us to study such quantitative correlations, but it should be remarked that the patient with the greatest memory and reasoning deficits also exhibited the lowest flows (case 6). To be compared with this finding were the results of our study on normals that demonstrated a positive significant relationship between the flow changes during memory activation and a shortterm memory score. 37 Our results suggested that CBF measurement using SPECT is sensitive and reliable enough to demonstrate asymmetries or focal abnormalities in patients with dementia of the Alzheimer type whereas CT scan usually failed to show such local alterations. Furthermore, these alterations strongly correlated with the neuropsychological tests. As stressed by Khachaturian38 "the validation of diagnostic tests remains a crucial problem in all areas of Alzheimer's disease research but especially in the area of neuropsychology". In our work, measuring cerebral blood flow by SPECT thus appeared a good means of consolidating the neuropsychological findings in DAT. In other respects, recent works have emphasised the variability of cognitive profiles39 or regional metabolic rates of glucose40 in DAT. Reviewing the models currently developed for Alzheimer's disease, Wurtman4 ' said that each model was supported by some observational or experimental evidence, and each seemed to be contradicted by other evidence. Indeed, our work, together with others, 1 34 39 40 points to variability in the clinical expression of the disease, which is the reason why none of the models perfectly matches the observed facts. But it also supports the idea that, combining clinical and neuropsychological examinations with functional mapping of the brain, a subtyping of DAT could be achieved. Thus, for instance, the bilateral posterior decrease in flow or metabolism, a finding now well established,69 would be ascribed in the subgroup of patients presenting with aphasia, apraxia and agnosia, a subgroup actually different from that of patients with focal abnormality and selective cognitive deficit (such as those presented here), or from that of patients with generalised hypoperfusion or hypometabolism and preponderant memory loss.34 To establish such a subtyping would really appear of prime interest as the prognosis could be different and as appropriate treatment could be proposed according to the subgroup.
Focal hypoperfusion in dementia of Alzheimer type
To fulfill the latter point supposes that the aetiology and the pathogenetic mechanisms of the disease be elucidated. In this respect too, a subtyping would be rewarding. The factors responsible for the local development of hypoperfusion or hypometabolism have not been determined. The circumscribed decrease in flow could be due to a local amyloid angiopathy which has been observed in Alzheimer's disease.32 42 Most of the time, a generalised process was observed, involving the whole brain, but recent work has demonstrated unifocal alterations that could account for our focal hypoperfusions. 43 Besides, in case of amyloid angiopathy, the blood-brain barrier (BBB) might be disrupted, as suggested by Elovaara et al. 44 This local disruption could in turn lead to neuronal alterations via the intrusion of neurotoxic proteins. In this case, the focal blood flow changes would represent the early stage of the disease. However, Friedland et al,45 using rubidium-82 and PET failed to demonstrate a local permeability of the BBB in patients with generalised DAT. The cortical hypoperfusions we observed might also represent the transynaptic consequence of the degeneration of subcortical cholinergic neurons observed in Alzheimer's disease or senile dementia.4647 However, were the subcortical cholinergic neurons the primary focus of the pathological process involved in our cases, the unilateral and rather limited hypoperfusion we observed after years of progression of the disease would appear somewhat disconcerting. Alternatively, the dysfunctional area might reflect a regional, cortical neuronal loss, as suggested by Brun et al. 5 The neuronal loss could mainly affect the somatostatin neurons, as suggested by Crow et a148 who found a reduction in somatostatin in the frontal and temporal cortices of patients with DAT, as well as a relationship between the location of neurofibrilliary tangles and the somatostatin-containing cell bodies and who considered these cells as a possible site of primary disturbance. However, whatever the pathogenetic mechanisms involved in DAT, a local biopsy, whenever possible, would still be needed to establish the diagnosis.
Nevertheless, assessing regional cerebral blood flow by SPECT has proved interesting. 
